Johnny Yang

1.4k total citations
30 papers, 1.1k citations indexed

About

Johnny Yang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Johnny Yang has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Johnny Yang's work include Drug Transport and Resistance Mechanisms (8 papers), Microtubule and mitosis dynamics (4 papers) and Cancer Genomics and Diagnostics (3 papers). Johnny Yang is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Microtubule and mitosis dynamics (4 papers) and Cancer Genomics and Diagnostics (3 papers). Johnny Yang collaborates with scholars based in United States, Japan and India. Johnny Yang's co-authors include Chenxi Xia, R B Kim, Vincent H.L. Lee, Hideo UEDA, Vincent H. L. Lee, Jasmine Davda, Mohamed G. Qaddoumi, Vinod Labhasetwar, Cindy Q. Xia and Pratik Saha and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Journal of Controlled Release.

In The Last Decade

Johnny Yang

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johnny Yang United States 15 502 382 156 150 130 30 1.1k
Maria Palmisano United States 23 385 0.8× 503 1.3× 58 0.4× 27 0.2× 63 0.5× 85 1.5k
W J Nooijen Netherlands 19 1.3k 2.6× 528 1.4× 314 2.0× 96 0.6× 62 0.5× 29 1.9k
J. H. Beijnen Netherlands 20 810 1.6× 412 1.1× 305 2.0× 64 0.4× 44 0.3× 47 1.4k
Hilary Thomas United Kingdom 17 808 1.6× 606 1.6× 132 0.8× 28 0.2× 67 0.5× 26 1.4k
Françoise Hervé France 17 320 0.6× 1.0k 2.7× 46 0.3× 91 0.6× 144 1.1× 49 1.6k
Deep Kwatra United States 16 195 0.4× 238 0.6× 70 0.4× 80 0.5× 49 0.4× 28 810
Willem J. Nooijen Netherlands 14 1.1k 2.3× 343 0.9× 323 2.1× 113 0.8× 38 0.3× 21 1.6k
Cindy Q. Xia United States 20 777 1.5× 481 1.3× 307 2.0× 51 0.3× 50 0.4× 47 1.4k
Alain Deroussent France 21 402 0.8× 529 1.4× 125 0.8× 37 0.2× 30 0.2× 47 1.5k
Masanori Miwa Japan 14 2.0k 3.9× 999 2.6× 112 0.7× 46 0.3× 66 0.5× 33 3.0k

Countries citing papers authored by Johnny Yang

Since Specialization
Citations

This map shows the geographic impact of Johnny Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnny Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnny Yang more than expected).

Fields of papers citing papers by Johnny Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnny Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnny Yang. The network helps show where Johnny Yang may publish in the future.

Co-authorship network of co-authors of Johnny Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Johnny Yang. A scholar is included among the top collaborators of Johnny Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johnny Yang. Johnny Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lewis, Shirley, et al.. (2024). India's Potential as a Leader in Cancer Care Progress in the Future: A Synthetic Interdisciplinary Perspective. Cureus. 16(10). e70892–e70892. 3 indexed citations
4.
5.
Yang, Johnny, et al.. (2024). Precision Population Cancer Medicine in Cancer of the Uterine Cervix: A Potential Roadmap to Eradicate Cervical Cancer. Cureus. 16(2). e53733–e53733. 4 indexed citations
6.
Yang, Johnny, et al.. (2023). SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma. Molecular Oncology. 18(3). 641–661. 8 indexed citations
7.
Yang, Johnny, et al.. (2023). An Overview of the Use of Precision Population Medicine in Cancer Care: First of a Series. Cureus. 15(4). e37889–e37889. 9 indexed citations
8.
Cafer, Anne, Meagen Rosenthal, Parker Smith, et al.. (2022). Examining the context, logistics, and outcomes of food prescription programs: A scoping review. Research in Social and Administrative Pharmacy. 19(1). 57–68. 17 indexed citations
9.
Vijayakumar, Srinivasan, et al.. (2022). Changing Role of PET/CT in Cancer Care With a Focus on Radiotherapy. Cureus. 14(12). e32840–e32840. 12 indexed citations
10.
Gallery, Melissa, Daniel P. Bradley, Pamela P. Brauer, et al.. (2018). A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo. PLoS ONE. 13(1). e0191046–e0191046. 20 indexed citations
11.
Xia, Cindy Q., et al.. (2015). Synthesis of a new inhibitor of breast cancer resistance protein with significantly improved pharmacokinetic profiles. Bioorganic & Medicinal Chemistry Letters. 26(2). 551–555. 14 indexed citations
12.
Kraynov, Eugenia, Ajith V. Kamath, Markus Walles, et al.. (2015). Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White Paper. Drug Metabolism and Disposition. 44(5). 617–623. 70 indexed citations
13.
Palani, Santhosh, Jessica J. Huck, Mengkun Zhang, et al.. (2013). Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase. Cancer Chemotherapy and Pharmacology. 72(6). 1255–1264. 19 indexed citations
14.
Honda, Kohei, Hitoshi Miyashita, Saomi Murai, et al.. (2011). TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens. Molecular Cancer Therapeutics. 11(3). 700–709. 64 indexed citations
15.
Xia, Chenxi, et al.. (2011). Drug Transporters in Drug Efficacy and Toxicity. The Annual Review of Pharmacology and Toxicology. 52(1). 249–273. 272 indexed citations
16.
Yang, Johnny, Mark Milton, Shaoxia Yu, et al.. (2010). P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor. Drug Metabolism Letters. 4(4). 202–212. 43 indexed citations
17.
Yang, Johnny, David K. Ann, Ram Kannan, & Vincent H.L. Lee. (2007). Multidrug Resistance Protein 1 (MRP1) in Rabbit Conjunctival Epithelial Cells: Its Effect on Drug Efflux and Its Regulation by Adenoviral Infection. Pharmaceutical Research. 24(8). 1490–1500. 21 indexed citations
18.
Yang, Johnny, et al.. (2000). Role of P-Glycoprotein in Restricting Propranolol Transport in Cultured Rabbit Conjunctival Epithelial Cell Layers. Pharmaceutical Research. 17(5). 533–538. 55 indexed citations
19.
Yang, Johnny, et al.. (2000). Meeting future challenges in topical ocular drug delivery:. Journal of Controlled Release. 65(1-2). 1–11. 30 indexed citations
20.
Xia, Cindy Q., Johnny Yang, Shijun Ren, & Eric J. Lien. (1998). QSAR Analysis of Polyamine Transport Inhibitors in L1210 Cells. Journal of drug targeting. 6(1). 65–77. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Palmisano Breakdown of academic impact, for papers by W J Nooijen Breakdown of academic impact, for papers by J. H. Beijnen Breakdown of academic impact, for papers by Hilary Thomas Breakdown of academic impact, for papers by Françoise Hervé Breakdown of academic impact, for papers by Deep Kwatra Breakdown of academic impact, for papers by Willem J. Nooijen Breakdown of academic impact, for papers by Cindy Q. Xia Breakdown of academic impact, for papers by Alain Deroussent Breakdown of academic impact, for papers by Masanori Miwa
Rankless by CCL
2026